MINI FUTURE LONG - VETOQUINOL Stock

Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets (67.7% of net sales; dogs, cats, etc.) and livestock (32.3%; cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families: - antibiotics; - anti-inflammatories; - cardiology and nephrology treatments; - other: anti-parasitics, vaccines, and nutritional products. At the end of 2022, the group had 5 production sites throughout the world. Net sales are distributed geographically as follows: Europe (46.7%), the Americas (36%) and Asia/Pacific (17.3%).